Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1835 studies found for:    "Ovarian Neoplasms"
Show Display Options
Rank Status Study
1 Unknown  Biobehavioral Influences and the Ovarian Tumor Microenvironment
Condition: Ovarian Neoplasms
Intervention:
2 Completed ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Drug: Sagopilone (ZK 219477) + carboplatin
3 Active, not recruiting [18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer
Condition: Ovarian Neoplasm
Intervention: Drug: Pazopanib and paclitaxel
4 Completed
Has Results
Bevacizumab and Erlotinib Study in Advanced Ovarian Cancer
Condition: Ovarian Neoplasms
Interventions: Drug: bevacizumab;   Drug: erlotinib
5 Terminated Efficacy Study of Additional Intraperitoneal Chemotherapy to Treat Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Drug: IP chemotherapy
6 Completed Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms
Condition: Ovarian Neoplasms
Intervention: Procedure: removal of ovarian vessels
7 Completed A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse)
Condition: Ovarian Neoplasm
Intervention:
8 Completed Study of OSI-211 vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Drug: OSI-211 (Liposomal Lurtotecan)
9 Completed DOXIL for Consolidation Therapy in Ovarian Cancer.
Condition: Ovarian Neoplasm
Intervention: Drug: liposomal doxorubicin
10 Recruiting Evaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass.
Condition: Ovarian Neoplasms
Interventions: Procedure: Pelvic imaging;   Procedure: Blood draw;   Procedure: laparotomy or laparoscopy
11 Active, not recruiting Lymphadenectomy In Ovarian Neoplasms
Condition: Ovarian Cancer
Interventions: Procedure: No Lymphadenectomy (LNE);   Procedure: Lymphadenectomy (LNE)
12 Active, not recruiting
Has Results
Dose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian Cancer
Condition: Ovarian Neoplasms
Interventions: Drug: AZD2281;   Drug: Liposomal Doxorubicin
13 Completed A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer
Condition: Ovarian Neoplasm
Interventions: Drug: Cyclophosphamide;   Drug: Paclitaxel;   Drug: Cisplatin;   Drug: G-CSF
14 Completed
Has Results
AZD0530 Phase II Study in Patients With Advanced Ovarian Cancer
Conditions: Ovarian Neoplasms;   Ovarian Cancer
Interventions: Drug: AZD0530;   Drug: Carboplatin;   Drug: Paclitaxel
15 Active, not recruiting
Has Results
Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer
Condition: Ovarian Neoplasm
Intervention: Drug: KU-0059436 (AZD2281)(PARP inhibitor)
16 Completed Study of the Combination Carboplatin Plus Celecoxib in Heavily Pre-treated Recurrent Ovarian Cancer Patients
Condition: Ovarian Neoplasms
Intervention: Drug: Carboplatin plus Celecoxib
17 Recruiting KOrean Borderline Ovarian Tumor (KOBOT) Registry
Condition: Ovarian Neoplasms
Intervention:
18 Completed MR-PET for Staging and Assessment of Operability in Ovarian Cancer - a Feasibility Study
Condition: Ovarian Neoplasms
Intervention: Radiation: MR-PET
19 Recruiting Evaluating the Performance of Morphology Index in Surgical Decision-Making for Ovarian Tumors
Condition: Ovarian Neoplasms
Intervention: Procedure: Abnormal Ovarian Ultrasound
20 Completed TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Drug: TLK286

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.